{"id":"W1964622370","doi":"10.1016/s0140-6736(02)09411-4","title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","year":2002,"lang":"en","type":"article","venue":"The Lancet","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":1528,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; AIDS Vancouver","funders":"Roche; Abbott Laboratories","keywords":"Medicine; Cohort; Viral load; Internal medicine; Hazard ratio; Proportional hazards model; Cohort study; Antiretroviral therapy; Prospective cohort study; Sida; Human immunodeficiency virus (HIV); Immunology; Confidence interval; Viral disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}